Want to join the conversation?
Biopharmaceutical company $BXLT said it presented data on the usage of ADYNOVATE in the treatment of patients with hemophilia A at the 57th American Society of Hematology (ASH) Annual Meeting. ADYNOVATE is a human antihemophilic factor indicated for treatment and control of bleeding episodes and to reduce frequency of bleeding episodes.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.